Where precision
meets clinical
intelligence.

Expert review and sign-off of promotional and medical materials — ensuring scientific accuracy, balance, and full compliance with EFPIA, LIF/LER, and local codes. Thorough, documented, and defensible.

Handling unsolicited medical information requests from HCPs — providing compliant, evidence-based responses with full documentation. A critical service that pharma teams consistently need external capacity for.

Drafting, reviewing, and maintaining SOPs, governance frameworks, and compliance documentation — aligned to EFPIA, local industry codes, and company standards. Audit-ready, always.

End-to-end management of investigator-sponsored research proposals — scientific review, compliance workflow, documentation, and ongoing oversight throughout the study lifecycle.

Building scientifically accurate and engaging training content on disease areas, product data, and scientific messaging — for KAM teams, commercial colleagues, and internal stakeholders.

Supporting publication strategy, manuscript development, and author coordination — from outline to submission. Aligned to GPP guidelines and your broader medical communications strategy.

Rigorous onsite monitoring visits ensuring protocol adherence, data integrity, and site compliance — drawing on direct experience educating investigators and site staff in patient management, sampling procedures, and safety reporting across multiple therapeutic areas and European markets.

End-to-end trial management — study start-up, site coordination, timeline oversight, risk management, and regulatory submissions. Operational discipline combined with scientific depth.

Clinical study reports, regulatory dossiers, protocols, investigator brochures, publications, and medical education materials — written with scientific precision and strategic clarity.

Translating global medical strategy into locally relevant, compliant medical plans — adapted to local clinical landscapes, healthcare systems, and regulatory environments across Nordic and European markets.

Identifying and mapping Key Opinion Leaders, planning non-promotional scientific exchange programmes, and building the HCP relationships that drive meaningful medical insight.

Full-service advisory board management — from KOL identification and scientific agenda design to back-office logistics, compliance sign-off, and output documentation that captures every insight.

Providing the medical and scientific narrative that supports HTA submissions, reimbursement dossiers, and payer discussions — translating clinical evidence into compelling access arguments.